Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus
NCT02445911
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
81
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
KQ-791
DRUG:
Placebo
Sponsor
Kaneq Bioscience Limited